Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Guo Chen
Based on 21 articles published since 2009
(Why 21 articles?)
||||
Expertise Level
The expertise of Guo Chen ranks in the
  • Top 0.91%
  • ... of 106,334 published authors worldwide on Melanoma
  • ... from 2009 through 2019
  • ... based on contributions to 21 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Work Locations
Details
Most likely:    University of Texas Houston   Contact    
2017
  • The Wistar Institute, Philadelphia, PA, 19104, USA. · The Wistar Institute, Philadelphia, PA, 19104, USA. · Department of Pathology and Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. · Division of Immunology, Allergy and Infectious Diseases (DIAID), Department of Dermatology, Medical University of Vienna, Vienna, A-1090, Austria. · New Jersey Institute of Technology, Newark, NJ, 07102, USA. · Department of Dermatology and Venereology, Karl Landsteiner University of Health Sciences, St. Pölten, A-3100, Austria. · Department of Radiology, Division of Nuclear Medicine, Medical University of Vienna, Vienna, A-1090, Austria. · Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Vienna, A-1090, Austria. · Department of Dermatology and Venereology, The Rudolfstiftung Hospital, Teaching Hospital of the Medical University Vienna, Vienna, A-1030, Austria. · Department of Dermatology, Paracelsus Medical University Salzburg, Salzburg, A-5020, Austria. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77040, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77040, USA. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, 02115, USA. · Melanoma Institute of Australia, and The University of Sydney, Sydney, 2065, Australia. · Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, 19104, USA. · Abramson Cancer Center, Hospital of University of Pennsylvania, Philadelphia, PA, 19104, USA. · SRI International, Menlo Park, CA, 94025, USA. · CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, A-1090, Austria. · Department of Biochemistry, McGill University, Montreal, QC, Canada, H3A0G4. · Dermatology Research Center, University of Queensland Diamantina Institute, The University of Queensland, Translational Research Institute, Brisbane, 4102, Australia. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer, Center, Houston, TX, 77040, USA. · Moffitt Cancer Center, Tampa, FL, 33612, USA. · The Wistar Institute, Philadelphia, PA, 19104, USA. · Division of Immunology, Allergy and Infectious Diseases (DIAID), Department of Dermatology, Medical University of Vienna, Vienna, A-1090, Austria. · Pubmed 28928360
2016
  • Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston. · Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Departments of Pathology and Translational and Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston. · Broad Institute, Cambridge, Massachusetts. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston7Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston. · Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston. · Massachusetts General Hospital, Boston. · California Pacific Medical Center Research Institute, San Francisco. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston11Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston. · Pubmed 27124486
  • Department of Cell and Molecular Biology, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil. · National Institute of Science and Technology in Stem Cell and Cell Therapy and Center for Cell-Based Therapy, Ribeirão Preto, São Paulo, Brazil. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Clinical Oncology, Stem Cell and Cell Therapy Program, Ribeirão Preto Medical School, Ribeirão Preto, São Paulo, Brazil. · Department of Genetics, Ribeirão Preto Medical School, and Center for Integrative System Biology (CISBi-NAP/USP), University of São Paulo, Ribeirão Preto, São Paulo, Brazil. · Pubmed 27167340
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, University of Chicago, Chicago, Illinois. · Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, Yale University School of Medicine, New Haven, Connecticut. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 26645196
2015
  • Department of Oncological Sciences, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA. · Hormel Institute, University of Minnesota, Austin, MN 55912, USA. · Department of Chemistry, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA. · Department of Oncological Sciences, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA; Department of Surgery, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA; Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA. · Department of Oncological Sciences, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA; Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA; Department of Dermatology, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA. · Department of Oncological Sciences, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA; Department of Surgery, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA; Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA. Electronic address: · Pubmed 26565903
2014
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 904, Houston, TX 77030, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 904, Houston, TX 77030, USA. Electronic address: · Pubmed 24880945
  • Departments of Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Melanoma Institute of Australia and Westmead Hospital, Sydney, Australia. · Departments of Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Massachusetts General Hospital, Boston, Massachusetts. · Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Department of Pediatrics, University of Cincinnati, Cincinatti, Ohio. · Department of Systems Biology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Department of Bioinformatics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Astra Zeneca, Macclesfield, United Kingdom. · Departments of Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. Department of Systems Biology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Pubmed 25297634
  • Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 25165098
  • Departments of Melanoma Medical Oncology, · Pathology. · Novartis Institutes for Biomedical Research, Emeryville, California; and. · Division of Medical Genetics, Department of Medicine, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania. · Systems Biology and. · Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; · Departments of Melanoma Medical Oncology. · Departments of Melanoma Medical Oncology, Systems Biology and. · Pubmed 24803579
  • The Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, Queensland, Australia. · Division of Laboratory and Genomic Medicine, Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri, USA. · Genetic Disease Research Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA. · NIH Intramural Sequencing Center, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Division of Medical Oncology, University of Colorado School of Medicine, Aurora, Colorado, USA. · The Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. · Genome Informatics Section, Genome Technology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA. · The Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA. Electronic address: · Pubmed 24008424
2017
  • aThe Hormel Institute, University of Minnesota, Austin, Minnesota bDepartment of Medicine and Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania Departments of cOncological Sciences dSurgery eDermatology fHuntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, Utah gDepartment of Tumor Biology, Tumor Biology hDepartment of Cutaneous Oncology, Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida iDepartment of Medicine, Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital jDepartment of Global Health, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, DC kDepartment of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 29076949
Probable:    Nanjing University      
2017
  • School of Life Sciences and Collaborative Innovation Center of Chemistry for Life Sciences, School of Stomatology, Affiliated Stomatological Hospital, Nanjing University, Nanjing 210023, People's Republic of China. · Changzhou High-Tech Research Institute of Nanjing University and Jiangsu TargetPharma Laboratories Inc., Changzhou 213164, P. R. China. · Pubmed 28740548
2013
  • The State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, 22 Hankou Road, Nanjing 210093, People's Republic of China. · Pubmed 22868826
2009
  • Jiangsu Center of Hepatobiliary Diseases and the State Key Laboratory of Pharmaceutical Biotechnology, Affiliated Gulou Hospital, Nanjing University, Nanjing 210093, China. · Pubmed 19793349
2012
  • The State Key Laboratory of Pharmaceutical Biotechnology and School of Stomatology, Affiliated Stomatological Hospital, Nanjing University, Nanjing, China. · Pubmed 22054098
2011
  • State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, PR China. · Pubmed 22000948
  • The State Key Laboratory of Pharmaceutical Biotechnology and School of Stomatology, Affiliated Stomatological Hospital, Nanjing University, Nanjing, P R China. · Pubmed 21474796
Probable:    Emory University   Contact    
2017
  • Central laboratory, General Surgery, Putuo Hospital, and Interventional Cancer Institute of Chinese Integrative Medicine, Shanghai University of Traditional Chinese Medicine, 164 Lanxi Rd, Shanghai 200062, PR China. · Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA. · Tianjin Key Laboratory of Molecular Design and Drug Discovery, Tianjin Institute of Pharmaceutical Research, Tianjin 300193, China. · School of Pharmacy, Institute for Liver Diseases of Anhui Medical University, ILDAMU, Key Laboratory of Anti-inflammatory and Immune Medicine, Anhui Medical University, Hefei, 230032, China. · State Key Laboratory of Membrane Biology, School of Medicine, School of Life Sciences, Tsinghua University, Beijing 100084, China. · Department of Clinical Laboratory, Tianjin Huanhu Hospital, Tianjin Key Laboratory of Cerebral Vessels and Neural Degeneration, Tianjin 300350, China. · State Key Laboratory of Bioreactor Engineering &Shanghai Key Laboratory of New drug design, School of pharmacy, East China University of Science and Technology, 130 Meilong Rd, Shanghai 200237, PR China. · Department of Pediatrics, Division of Hematology/Oncology, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA 30322, USA. · Pubmed 28176801
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 21 total) written by Guo Chen about Melanoma:

  • Tumor-associated B-cells induce tumor heterogeneity and therapy resistance. 2017
  • Resistance mechanisms to genetic suppression of mutant NRAS in melanoma. 2017
  • Modulation of 2017
  • MFN2 suppresses cancer progression through inhibition of mTORC2/Akt signaling. 2017
  • Clinical, Molecular, and Immune Analysis of Dabrafenib-Trametinib Combination Treatment for BRAF Inhibitor-Refractory Metastatic Melanoma: A Phase 2 Clinical Trial. 2016
  • RMEL3, a novel BRAFV600E-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanoma. 2016
  • Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy. 2016
  • AKT1 Activation Promotes Development of Melanoma Metastases. 2015
  • Genetic vaccines to potentiate the effective CD103+ dendritic cell-mediated cross-priming of antitumor immunity. 2015
  • Targeted therapy resistance mechanisms and therapeutic implications in melanoma. 2014
Show List of Full Article Records
Google Searches

Learn more about Guo Chen using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Texas Houston
Nanjing University
Emory University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Texas Houston
2017
  • The Wistar Institute, Philadelphia, PA, 19104, USA. · The Wistar Institute, Philadelphia, PA, 19104, USA. · Department of Pathology and Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. · Division of Immunology, Allergy and Infectious Diseases (DIAID), Department of Dermatology, Medical University of Vienna, Vienna, A-1090, Austria. · New Jersey Institute of Technology, Newark, NJ, 07102, USA. · Department of Dermatology and Venereology, Karl Landsteiner University of Health Sciences, St. Pölten, A-3100, Austria. · Department of Radiology, Division of Nuclear Medicine, Medical University of Vienna, Vienna, A-1090, Austria. · Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Vienna, A-1090, Austria. · Department of Dermatology and Venereology, The Rudolfstiftung Hospital, Teaching Hospital of the Medical University Vienna, Vienna, A-1030, Austria. · Department of Dermatology, Paracelsus Medical University Salzburg, Salzburg, A-5020, Austria. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77040, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77040, USA. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, 02115, USA. · Melanoma Institute of Australia, and The University of Sydney, Sydney, 2065, Australia. · Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, 19104, USA. · Abramson Cancer Center, Hospital of University of Pennsylvania, Philadelphia, PA, 19104, USA. · SRI International, Menlo Park, CA, 94025, USA. · CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, A-1090, Austria. · Department of Biochemistry, McGill University, Montreal, QC, Canada, H3A0G4. · Dermatology Research Center, University of Queensland Diamantina Institute, The University of Queensland, Translational Research Institute, Brisbane, 4102, Australia. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer, Center, Houston, TX, 77040, USA. · Moffitt Cancer Center, Tampa, FL, 33612, USA. · The Wistar Institute, Philadelphia, PA, 19104, USA. · Division of Immunology, Allergy and Infectious Diseases (DIAID), Department of Dermatology, Medical University of Vienna, Vienna, A-1090, Austria. · Pubmed 28928360
2016
  • Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston. · Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Departments of Pathology and Translational and Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston. · Broad Institute, Cambridge, Massachusetts. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston7Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston. · Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston. · Massachusetts General Hospital, Boston. · California Pacific Medical Center Research Institute, San Francisco. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston11Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston. · Pubmed 27124486
  • Department of Cell and Molecular Biology, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil. · National Institute of Science and Technology in Stem Cell and Cell Therapy and Center for Cell-Based Therapy, Ribeirão Preto, São Paulo, Brazil. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Clinical Oncology, Stem Cell and Cell Therapy Program, Ribeirão Preto Medical School, Ribeirão Preto, São Paulo, Brazil. · Department of Genetics, Ribeirão Preto Medical School, and Center for Integrative System Biology (CISBi-NAP/USP), University of São Paulo, Ribeirão Preto, São Paulo, Brazil. · Pubmed 27167340
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, University of Chicago, Chicago, Illinois. · Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, Yale University School of Medicine, New Haven, Connecticut. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 26645196
2015
  • Department of Oncological Sciences, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA. · Hormel Institute, University of Minnesota, Austin, MN 55912, USA. · Department of Chemistry, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA. · Department of Oncological Sciences, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA; Department of Surgery, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA; Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA. · Department of Oncological Sciences, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA; Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA; Department of Dermatology, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA. · Department of Oncological Sciences, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA; Department of Surgery, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA; Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA. Electronic address: · Pubmed 26565903
2014
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 904, Houston, TX 77030, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 904, Houston, TX 77030, USA. Electronic address: · Pubmed 24880945
  • Departments of Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Melanoma Institute of Australia and Westmead Hospital, Sydney, Australia. · Departments of Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Massachusetts General Hospital, Boston, Massachusetts. · Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Department of Pediatrics, University of Cincinnati, Cincinatti, Ohio. · Department of Systems Biology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Department of Bioinformatics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Astra Zeneca, Macclesfield, United Kingdom. · Departments of Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. Department of Systems Biology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Pubmed 25297634
  • Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 25165098
  • Departments of Melanoma Medical Oncology, · Pathology. · Novartis Institutes for Biomedical Research, Emeryville, California; and. · Division of Medical Genetics, Department of Medicine, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania. · Systems Biology and. · Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; · Departments of Melanoma Medical Oncology. · Departments of Melanoma Medical Oncology, Systems Biology and. · Pubmed 24803579
  • The Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, Queensland, Australia. · Division of Laboratory and Genomic Medicine, Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri, USA. · Genetic Disease Research Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA. · NIH Intramural Sequencing Center, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Division of Medical Oncology, University of Colorado School of Medicine, Aurora, Colorado, USA. · The Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. · Genome Informatics Section, Genome Technology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA. · The Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA. Electronic address: · Pubmed 24008424
2017
  • aThe Hormel Institute, University of Minnesota, Austin, Minnesota bDepartment of Medicine and Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania Departments of cOncological Sciences dSurgery eDermatology fHuntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, Utah gDepartment of Tumor Biology, Tumor Biology hDepartment of Cutaneous Oncology, Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida iDepartment of Medicine, Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital jDepartment of Global Health, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, DC kDepartment of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 29076949
Nanjing University
2017
  • School of Life Sciences and Collaborative Innovation Center of Chemistry for Life Sciences, School of Stomatology, Affiliated Stomatological Hospital, Nanjing University, Nanjing 210023, People's Republic of China. · Changzhou High-Tech Research Institute of Nanjing University and Jiangsu TargetPharma Laboratories Inc., Changzhou 213164, P. R. China. · Pubmed 28740548
2013
  • The State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, 22 Hankou Road, Nanjing 210093, People's Republic of China. · Pubmed 22868826
2009
  • Jiangsu Center of Hepatobiliary Diseases and the State Key Laboratory of Pharmaceutical Biotechnology, Affiliated Gulou Hospital, Nanjing University, Nanjing 210093, China. · Pubmed 19793349
2012
  • The State Key Laboratory of Pharmaceutical Biotechnology and School of Stomatology, Affiliated Stomatological Hospital, Nanjing University, Nanjing, China. · Pubmed 22054098
2011
  • State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, PR China. · Pubmed 22000948
  • The State Key Laboratory of Pharmaceutical Biotechnology and School of Stomatology, Affiliated Stomatological Hospital, Nanjing University, Nanjing, P R China. · Pubmed 21474796
Emory University
2017
  • Central laboratory, General Surgery, Putuo Hospital, and Interventional Cancer Institute of Chinese Integrative Medicine, Shanghai University of Traditional Chinese Medicine, 164 Lanxi Rd, Shanghai 200062, PR China. · Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA. · Tianjin Key Laboratory of Molecular Design and Drug Discovery, Tianjin Institute of Pharmaceutical Research, Tianjin 300193, China. · School of Pharmacy, Institute for Liver Diseases of Anhui Medical University, ILDAMU, Key Laboratory of Anti-inflammatory and Immune Medicine, Anhui Medical University, Hefei, 230032, China. · State Key Laboratory of Membrane Biology, School of Medicine, School of Life Sciences, Tsinghua University, Beijing 100084, China. · Department of Clinical Laboratory, Tianjin Huanhu Hospital, Tianjin Key Laboratory of Cerebral Vessels and Neural Degeneration, Tianjin 300350, China. · State Key Laboratory of Bioreactor Engineering &Shanghai Key Laboratory of New drug design, School of pharmacy, East China University of Science and Technology, 130 Meilong Rd, Shanghai 200237, PR China. · Department of Pediatrics, Division of Hematology/Oncology, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA 30322, USA. · Pubmed 28176801
University of Pittsburgh
2015
  • Department of Dermatology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213; · Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110; Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, MO 63110; · Department of Dermatology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213; and University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213. · Department of Dermatology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213; and University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213 · Pubmed 25972487
11 Other Locations Show
Yearly article counts 00432522201
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.